Sumit Aggarwal
PRESIDENT AND CEO at Eloxx Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Eloxx Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Eloxx Pharmaceuticals Inc. June 22, 202399.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 28, 2026 | Eloxx Pharmaceuticals Inc. | Option exercise | +260,946 | $0.15 | $39,142 |
| Jan 24, 2026 | Eloxx Pharmaceuticals Inc. | Option exercise | +15,000 | — | — |
| Sep 19, 2025 | Eloxx Pharmaceuticals Inc. | Grant or award | +1,000,000 | — | — |
| Aug 14, 2025 | Eloxx Pharmaceuticals Inc. | Option exercise | +196,880 | — | — |
| Jan 24, 2025 | Eloxx Pharmaceuticals Inc. | Option exercise | +30,000 | — | — |
| Oct 16, 2024 | Eloxx Pharmaceuticals Inc. | Grant or award | +165,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.